Literature DB >> 36038770

Single-cell RNA transcriptomic analysis identifies Creb5 and CD11b-DCs as regulator of asthma exacerbations.

Xiaojie Liu1, Keilah G Netto2, Leon A Sokulsky2, Lujia Zhou1, Huisha Xu1, Chi Liu3, Ming Wang4, Huaqi Wang5, Hui Li5, Guojun Zhang5, Paul S Foster2, Fuguang Li6, Ming Yang7,8.   

Abstract

Immune responses that result in asthma exacerbation are associated with allergen or viral exposure. Identification of common immune factors will be beneficial for the development of uniformed targeted therapy. We employed a House Dust Mite (HDM) mouse model of asthma and challenged allergic HDM mice with allergens (HDM, cockroach extract (CRE)) or respiratory syncytial virus (RSV). Purified lung immune cells underwent high-dimensional single-cell RNA deep sequencing (scRNA-seq) to generate an RNA transcriptome. Gene silencing with siRNA was employed to confirm the efficacy of scRNA-seq analysis. scRNA-seq UMAP analysis portrayed an array of cell markers within individual immune clusters. SCENIC R analysis showed an increase in regulon number and activity in CD11b- DC cells. Analysis of conserved regulon factors further identified Creb5 as a shared regulon between the exacerbation groups. Creb5 siRNAs attenuated HDM, CRE or RSV-induced asthma exacerbation. scRNA-seq multidimensional analysis of immune clusters identified gene pathways that were conserved between the exacerbation groups. We propose that these analyses provide a strong framework that could be used to identify specific therapeutic targets in multifaceted pathologies.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36038770     DOI: 10.1038/s41385-022-00556-1

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   8.701


  54 in total

Review 1.  Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations.

Authors:  Patrick G Holt; Deborah H Strickland
Journal:  J Allergy Clin Immunol       Date:  2010-04-15       Impact factor: 10.793

Review 2.  Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.

Authors:  Paraskevi Katsaounou; Roland Buhl; Guy Brusselle; Pascal Pfister; Rafael Martínez; Ulrich Wahn; Jean Bousquet
Journal:  Respir Med       Date:  2019-02-07       Impact factor: 3.415

3.  Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation.

Authors:  Jessica S Siegle; Nicole Hansbro; Cristan Herbert; Ming Yang; Paul S Foster; Rakesh K Kumar
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 4.  Asthma outcomes: exacerbations.

Authors:  Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

Review 5.  Therapeutic significance of distal airway inflammation in asthma.

Authors:  Richard J Martin
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

Review 6.  Novel monoclonal treatments in severe asthma.

Authors:  Howraman Meteran; Hanieh Meteran; Celeste Porsbjerg; Vibeke Backer
Journal:  J Asthma       Date:  2017-03-13       Impact factor: 2.515

Review 7.  Asthma exacerbations . 3: Pathogenesis.

Authors:  P A B Wark; P G Gibson
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

8.  Inflammatory cell mapping of the respiratory tract in fatal asthma.

Authors:  S de Magalhães Simões; M A dos Santos; M da Silva Oliveira; E S Fontes; S Fernezlian; A L Garippo; I Castro; F F M Castro; M de Arruda Martins; P H N Saldiva; T Mauad; M Dolhnikoff
Journal:  Clin Exp Allergy       Date:  2005-05       Impact factor: 5.018

9.  Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Kay K Guntupalli; Peter K Jeffery
Journal:  Thorax       Date:  2007-01-18       Impact factor: 9.139

Review 10.  Asthma exacerbations: origin, effect, and prevention.

Authors:  David J Jackson; Annemarie Sykes; Patrick Mallia; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2011-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.